> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Drug Safety Reporting Extension
- URL: https://www.fdaweb.com/comments-sought-on-drug-safety-reporting-extension/
- Published: 2017-10-31T12:00:00.000Z
- Updated: 2026-09-14T22:59:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140005

*Federal Register* notice: FDA is seeking comments on an information collection extension on “Postmarketing Safety Reports for Human Drug and Biological Products: Waivers From Electronic Submission Requirements — OMB Control Number 0910–0770.” The rule requires that firms subject to mandatory reporting requirements submit safety reports in an electronic format that FDA can process, review, and archive. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-30/pdf/2017-23518.pdf?ref=fdaweb.com).